Service de Néphrologie-Dialyse-Transplantation, CHU d'Angers, Angers, France.
Université d'Angers, Inserm, CNRS, Nantes Université, CRCI2NA, Angers, France; Service de Pathologie, Université d'Angers, CHU d'Angers, Angers, France.
Autoimmun Rev. 2022 Sep;21(9):103139. doi: 10.1016/j.autrev.2022.103139. Epub 2022 Jul 11.
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are a group of multisystemic autoimmune diseases characterized by necrotizing inflammation of small vessels. Kidney involvement is frequent in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), and accounts for a significant proportion of the morbidity and mortality related to these diseases. Despite improvement in therapeutic management of ANCA-glomerulonephritis (ANCA-GN), end-stage kidney disease (ESKD) still occurs in up to 30% of affected patients within 5 years following diagnosis. Thus, identifying patients for whom aggressive immunosuppressive therapy will be more beneficial than deleterious is of great importance. Several clinical, biological and histological factors have been proposed as predictors of ESKD. The kidney biopsy is essential not only for the diagnosis, but also for evaluating renal prognosis. In this review, we discuss the prognostic value of renal lesions at the diagnosis of ANCA-GN by analyzing each compartment of the nephron. We also review existing ESKD risk classification in ANCA-GN and finally propose an example of a standardized pathology report that could be used in routine practice.
抗中性粒细胞胞质抗体(ANCA)相关性血管炎(AAV)是一组以小血管坏死性炎症为特征的多系统自身免疫性疾病。肾损害在肉芽肿性多血管炎(GPA)和显微镜下多血管炎(MPA)中较为常见,占这些疾病相关发病率和死亡率的很大一部分。尽管在治疗管理抗中性粒细胞胞质抗体肾小球肾炎(ANCA-GN)方面取得了进展,但在诊断后 5 年内,仍有多达 30%的受影响患者发展为终末期肾病(ESKD)。因此,确定哪些患者接受强化免疫抑制治疗将更有益而不是有害是非常重要的。已经提出了一些临床、生物学和组织学因素作为 ESKD 的预测因素。肾活检不仅对诊断很重要,而且对评估肾脏预后也很重要。在这篇综述中,我们通过分析肾单位的每个隔室来讨论 ANCA-GN 诊断时肾脏病变的预后价值。我们还回顾了目前在 ANCA-GN 中用于 ESKD 风险分类的方法,并最终提出了一个可以在常规实践中使用的标准化病理报告示例。